Methylergonovine

Breastfeeding
  • TRADE NAME: Methergine (Novartis)
  • INDICATIONS: Routine management after delivery of placenta, postpartum atony and hemorrhage; subinvolution
  • CLASS: Ergot alkaloid
  • HALF-LIFE: 1.5–12.7 hours

Our database has 9 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
GASTROINTESTINAL/HEPATIC
RESPIRATORY


Page last updated 05/04/2017

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric